Amgen Inc
HKEX:4332
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Amgen Inc
HKEX:4332
|
US |
|
L
|
Lipocine Inc
F:2VT
|
US |
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
Singapore Airlines Ltd
SGX:C6L
|
SG |
|
T
|
Telefonica SA
OTC:TEFOF
|
ES |
|
P
|
Peabody Energy Corp
SWB:PBE
|
US |
|
D
|
DENTSPLY SIRONA Inc
SWB:DY2
|
US |
Wall St Price Targets
Price Targets Summary
Amgen Inc
According to Wall Street analysts, the average 1-year price target for Amgen Inc is 1 099.47 HKD with a low forecast of 612.88 HKD and a high forecast of 1 376.26 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Amgen Inc's stock price target?
Price Target
1 099.47
HKD
According to Wall Street analysts, the average 1-year price target for Amgen Inc is 1 099.47 HKD with a low forecast of 612.88 HKD and a high forecast of 1 376.26 HKD.
What is the Revenue forecast for Amgen Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Amgen Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Amgen Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 8 years is 11%.
